J

JCR Pharmaceuticals Co Ltd
TSE:4552

Watchlist Manager
JCR Pharmaceuticals Co Ltd
TSE:4552
Watchlist
Price: 712 JPY -2.06% Market Closed
Market Cap: 92.3B JPY

Wall Street
Price Targets

Price Targets Summary
JCR Pharmaceuticals Co Ltd

Wall Street analysts forecast JCR Pharmaceuticals Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JCR Pharmaceuticals Co Ltd is 667.37 JPY with a low forecast of 555.5 JPY and a high forecast of 756 JPY.

Lowest
Price Target
555.5 JPY
22% Downside
Average
Price Target
667.37 JPY
6% Downside
Highest
Price Target
756 JPY
6% Upside
JCR Pharmaceuticals Co Ltd Competitors:
Price Targets
AUROPHARMA
Aurobindo Pharma Ltd
14% Upside
ABBOTINDIA
Abbott India Ltd
26% Upside
600195
China Animal Husbandry Industry Co Ltd
4% Upside
HIKAL
Hikal Ltd
36% Upside
600380
Joincare Pharmaceutical Group Industry Co Ltd
37% Upside
002001
Zhejiang Nhu Co Ltd
14% Upside

Revenue
Forecast

Revenue Estimate
JCR Pharmaceuticals Co Ltd

For the last 13 years the compound annual growth rate for JCR Pharmaceuticals Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 4%.

8%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
JCR Pharmaceuticals Co Ltd

Operating Income forecast
is not available for
JCR Pharmaceuticals Co Ltd

Net Income
Forecast

Net Income Estimate
JCR Pharmaceuticals Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JCR Pharmaceuticals Co Ltd's stock price target?
Price Target
667.37 JPY

According to Wall Street analysts, the average 1-year price target for JCR Pharmaceuticals Co Ltd is 667.37 JPY with a low forecast of 555.5 JPY and a high forecast of 756 JPY.

What is JCR Pharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for JCR Pharmaceuticals Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 4%.

Back to Top